Two Sigma Investments — SRPT Trade History

Quarter-by-quarter changes in the SAREPTA THERAPEUTICS INC position · CUSIP 803607100
Currently held · 5.5 YearsFirst seen: 2016 Q4
QuarterFiledActivitySharesΔ SharesΔ %Value% Port.
2026 Q22026-08-14Add4,598,7355,540+0.1%$82.6M0.06%
2026 Q12026-05-15Add4,593,1952,151,740+88.1%$99.9M0.08%
2025 Q42026-02-17Add2,441,455303,691+14.2%$52.5M0.07%
2025 Q32025-11-14Reduce2,137,764-23,933-1.1%$41.2M0.06%
2025 Q22025-08-14Add2,161,6971,610,817+292.4%$37.0M0.07%
2025 Q12025-05-15Add550,880475,826+634.0%$35.2M0.07%
2024 Q42025-02-14Reduce75,054-127,216-62.9%$9.1M0.02%
2024 Q32024-11-14Reduce202,270-339,524-62.7%$25.3M0.06%
2024 Q22024-08-14Add541,794199,112+58.1%$85.6M0.20%
2024 Q12024-05-15Add342,68240,342+13.3%$44.4M0.10%
2023 Q42024-02-14Reduce302,340-508,127-62.7%$29.2M0.07%
2023 Q32023-11-14Reduce810,467-478,731-37.1%$98.2M0.26%
2023 Q22023-08-14Add1,289,198192,055+17.5%$147.6M0.37%
2023 Q12023-05-15Add1,097,143405,737+58.7%$151.2M0.43%
2022 Q42023-02-14Reduce691,406-98,306-12.4%$89.6M0.28%
2022 Q32022-11-14Add789,712759,045+2475.1%$87.3M0.30%
2022 Q22022-08-15Reduce30,667-262,632-89.5%$2.3M0.01%
2022 Q12022-05-16Reduce293,299-512,962-63.6%$22.9M0.07%
2021 Q42022-02-14Add806,261553,885+219.5%$72.6M0.15%
2021 Q32021-11-15Add252,376231,409+1103.7%$23.3M0.05%
2021 Q22021-08-16Reduce20,967-65,300-75.7%$1.6M0.00%
2021 Q12021-05-17New86,26786,267$6.4M0.02%
2020 Q42021-02-16
2020 Q32020-11-16
2020 Q22020-08-14
2020 Q12020-05-15
2019 Q42020-02-14
2019 Q32019-11-14
2019 Q22019-08-14
2019 Q12019-05-15
2018 Q42019-02-14
2018 Q32018-11-14
2018 Q22018-08-14Sold out-56,203-100.0%
2018 Q12018-05-15New56,20356,203$4.2M0.01%
2017 Q42018-02-14
2017 Q32017-11-14
2017 Q22017-08-14
2017 Q12017-05-15Sold out-263,229-100.0%
2016 Q42017-02-14New263,229263,229$7.2M0.03%
2016 Q32016-11-14

Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.